** = Publikationen gelistet in SCI/SSCI/Pubmed
** Hatzl, S; Kriegl, L; Posch, F; Schilcher, G; Eller, P; Reisinger, A; Grinschgl, Y; Muhr, T; Meinitzer, A; Hoenigl, M; Krause, R
Early attainment of isavuconazole target concentration using an increased loading dose in critically ill patients with extracorporeal membrane oxygenation.
J Antimicrob Chemother. 2023; 78(12):2902-2908
Doi: 10.1093/jac/dkad328
Web of Science
PubMed
FullText
FullText_MUG
** Zurl, C; Waller, M; Schwameis, F; Muhr, T; Bauer, N; Zollner-Schwetz, I; Valentin, T; Meinitzer, A; Ullrich, E; Wunsch, S; Hoenigl, M; Grinschgl, Y; Prattes, J; Oulhaj, A; Krause, R
Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations.
J Fungi (Basel). 2020; 6(2):
Doi: 10.3390/jof6020090
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Prüller, F; Münch, A; Preininger, A; Raggam, RB; Grinschgl, Y; Krumnikl, J; Toller, W; Metzler, H; Mahla, E; Mangge, H
Comparison of functional fibrinogen (FF/CFF) and FIBTEM in surgical patients - a retrospective study.
Clin Chem Lab Med. 2016; 54(3):453-458
Doi: 10.1515/cclm-2015-0345
Web of Science
PubMed
FullText
FullText_MUG